On Monday, Tango Therapeutics Inc (NASDAQ: TNGX) opened lower -15.89% from the last session, before settling in for the closing price of $10.89. Price fluctuations for TNGX have ranged from $5.15 to $13.03 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 132.62% annually for the last half of the decade. Company’s average yearly earnings per share was noted -22.90% at the time writing. With a float of $57.42 million, this company’s outstanding shares have now reached $102.20 million.
In an organization with 140 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 94.15%, operating margin of -311.57%, and the pretax margin is -273.63%.
Tango Therapeutics Inc (TNGX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tango Therapeutics Inc is 46.40%, while institutional ownership is 56.74%. The most recent insider transaction that took place on Sep 05 ’24, was worth 867,135. In this transaction 10% Owner of this company sold 75,000 shares at a rate of $11.56, taking the stock ownership to the 16,926,475 shares. Before that another transaction happened on Sep 05 ’24, when Company’s Affiliate proposed sale 75,000 for $11.68, making the entire transaction worth $876,000.
Tango Therapeutics Inc (TNGX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -22.90% per share during the next fiscal year.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Check out the current performance indicators for Tango Therapeutics Inc (TNGX). In the past quarter, the stock posted a quick ratio of 7.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.13, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Tango Therapeutics Inc (TNGX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.49 million. That was better than the volume of 0.7 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 41.61%. Additionally, its Average True Range was 0.88.
During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 48.60%, which indicates a significant increase from 25.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 107.06% in the past 14 days, which was higher than the 71.84% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.83, while its 200-day Moving Average is $9.34. However, in the short run, Tango Therapeutics Inc’s stock first resistance to watch stands at $9.68. Second resistance stands at $10.20. The third major resistance level sits at $10.95. If the price goes on to break the first support level at $8.41, it is likely to go to the next support level at $7.66. The third support level lies at $7.14 if the price breaches the second support level.
Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats
There are currently 106,846K shares outstanding in the company with a market cap of 981.40 million. Presently, the company’s annual sales total 36,530 K according to its annual income of -101,740 K. Last quarter, the company’s sales amounted to 19,880 K and its income totaled -25,550 K.
